Clinical Trial Update: A Trial With EMP16 in Preparation for Late Phase Studies [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of EMP16 for overweight/obesity is not yet recruiting, as Empros Pharma AB prepares for late-phase studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• EMP16

Snippet

Sponsor: Empros Pharma AB | Conditions: Overweight or Obese, Obesity and Overweight | Phase 2 | Status: NOT_YET_RECRUITING